There are 36 resources available
Adjuvant treatment selection for localised RCC
Presenter: G. De Velasco, ES
Session: SESSION 4 - Debate around adjuvant therapy for RCC
Resources:
Slides
Webcast
Surgeon's point of view: Assessing the risk of relapse
Presenter: A. Bex, NL
Session: SESSION 4 - Debate around adjuvant therapy for RCC
Resources:
Slides
Webcast
Treatment after progression on adjuvant therapy in renal carcinoma
Presenter: U. Vogl, CH
Session: SESSION 4 - Debate around adjuvant therapy for RCC
Resources:
Slides
Webcast
Participants clinical case discussionRCC: From the adjuvant setting to metastatic, then complete response; when to stop/de-escalate immunotherapy?
Presenter: C. Handforth, UK
Session: SESSION 4 - Debate around adjuvant therapy for RCC
Resources:
Slides
Webcast
Participants clinical case discussion: The importance of metastasectomies in the management of Kidney Cancer
Presenter: V. Mentesidou, GR
Session: SESSION 4 - Debate around adjuvant therapy for RCC
Resources:
Slides
Webcast
Participants clinical case discussion: Debunking Myths: Can Patients with Autoimmune Diseases Receive Immunotherapy? A case of Renal Cell Carcinoma
Presenter: P. Mascaró Baselga, ES
Session: SESSION 4 - Debate around adjuvant therapy for RCC
Resources:
Slides
Webcast
Debate: Immune combinations or VEGF/PD1 inhibition as first line therapy for advanced clear cell RCC: Immune combinations
Presenter: L. Albiges, FR
Session: SESSION 5 - Renal Cancer – Part II
Resources:
Slides
Webcast
Debate: Immune combinations or VEGF/PD1 inhibition as first line therapy for advanced clear cell RCC: VEGF/PD1 inhibition
Presenter: V. Grünwald, DE
Session: SESSION 5 - Renal Cancer – Part II
Resources:
Slides
Webcast
Individualized therapy in frontline
Presenter: L. Albiges, FR
Session: SESSION 5 - Renal Cancer – Part II
Resources:
Slides
Webcast
Second line and beyond in RCC
Presenter: S. Zschäbitz, DE
Session: SESSION 5 - Renal Cancer – Part II
Resources:
Slides
Webcast